Literature DB >> 2479904

British and American recommendations for developmental monitoring: the role of surveillance.

P H Dworkin1.   

Abstract

Major British and American pediatric organizations have recently issued recommendations for developmental monitoring during preventive child health care. After initial inspection, similarities between the British and American recommendations are not apparent. For example, the Committee on Practice and Ambulatory Medicine of the American Academy of Pediatrics emphasizes the importance of assessing development during all child health supervision visits, whereas the British Joint Working Party on Child Health Surveillance discourages routine, repeated developmental examinations. Further analysis reveals, however, that such recommendations are compatible. Neither committee recommends the routine administration of developmental screening tests. Such recommendations are consistent with the lack of evidence to justify routine screening of all children for developmental problems. Instead, both committees suggest that developmental monitoring be performed by the process of surveillance. With developmental surveillance, the importance of eliciting parents' opinions and concerns, obtaining a relevant developmental history, and performing skilled, longitudinal observations of children is emphasized. The success of surveillance depends on the extent to which its implementation is enhanced through clinical practice, professional training, and research.

Entities:  

Mesh:

Year:  1989        PMID: 2479904

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

Review 1.  Early identification of neuro-developmental disorders.

Authors:  P D Singhi
Journal:  Indian J Pediatr       Date:  1992 Jan-Feb       Impact factor: 1.967

Review 2.  Developmental monitoring in primary care.

Authors:  C E Goldfarb; W Roberts
Journal:  Can Fam Physician       Date:  1996-08       Impact factor: 3.275

Review 3.  Screening for Social Determinants of Health Among Children and Families Living in Poverty: A Guide for Clinicians.

Authors:  Esther K Chung; Benjamin S Siegel; Arvin Garg; Kathleen Conroy; Rachel S Gross; Dayna A Long; Gena Lewis; Cynthia J Osman; Mary Jo Messito; Roy Wade; H Shonna Yin; Joanne Cox; Arthur H Fierman
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2016-04-18

4.  A Systematic Review of Part C Early Identification Studies.

Authors:  Brian Barger; Catherine Rice; Christina Anne Simmons; Rebecca Wolf
Journal:  Topics Early Child Spec Educ       Date:  2016-12-20

Review 5.  Autism and pediatric practice: toward a medical home.

Authors:  Susan L Hyman; Jara K Johnson
Journal:  J Autism Dev Disord       Date:  2012-06

6.  Applying surveillance and screening to family psychosocial issues: implications for the medical home.

Authors:  Arvin Garg; Paul H Dworkin
Journal:  J Dev Behav Pediatr       Date:  2011-06       Impact factor: 2.225

7.  Health promotion and research in the Chinese community in Montreal: A model of culturally appropriate health care.

Authors:  Alice Chan-Yip
Journal:  Paediatr Child Health       Date:  2004-11       Impact factor: 2.253

8.  Communication about child development during well-child visits: impact of parents' evaluation of developmental status screener with or without an informational video.

Authors:  Laura Sices; Dennis Drotar; Ashley Keilman; H Lester Kirchner; David Roberts; Terry Stancin
Journal:  Pediatrics       Date:  2008-11       Impact factor: 7.124

9.  Screening for developmental delay among children attending a rural community welfare clinic in Ghana.

Authors:  Ajediran I Bello; Jonathan N A Quartey; Louisa A Appiah
Journal:  BMC Pediatr       Date:  2013-08-13       Impact factor: 2.125

10.  Clinical utility of the Structured Observation of Motor Performance in Infants within the child health services.

Authors:  Kine Johansen; Kristina Persson; Karin Sonnander; Margaretha Magnusson; Anna Sarkadi; Steven Lucas
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.